Latest filing published 28 Jun 2017 for Vanc Pharmaceuticals Inc., €34k.
No signal scores available.
David M. Hall appears in our data through filings on Vanc Pharmaceuticals Inc. shares, published by SEDI. Over a trading history stretching from 21 January 2016 to 26 June 2017, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 28 June 2017, reports a transaction of €34k in Vanc Pharmaceuticals Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations